Literature DB >> 34455065

Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.

Anna Kerpel-Fronius1, Martin Tammemägi2, Milena Cavic3, Claudia Henschke4, Long Jiang5, Ella Kazerooni6, Choon-Taek Lee7, Luigi Ventura8, Dawei Yang9, Stephen Lam10, Rudolf M Huber11.   

Abstract

Screening with low-dose computed tomography of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss more than 50% of lung cancers, and in some geographic areas, such as East Asia, a large proportion of the missed lung cancers are in never-smokers. Although randomized trials revealed the benefits of screening for people who smoke, these trials generally excluded never-smokers. Thus, the feasibility and effectiveness of lung cancer screening of individuals who never smoked are uncertain. Several known and suspected risk factors for lung cancers in never-smokers such as exposure to secondhand smoke, occupational carcinogens, radon, air pollution, and pulmonary diseases, such as chronic obstructive pulmonary disease and interstitial lung diseases, and intrinsic factors, such as age, are well noted. In this regard, knowledge of risk factors may make possible quantification and prediction of lung cancer risk in never smokers. It is worth considering if and how never smokers could be included in population-based screening programs. As the implementation of these programs is challenging in many countries owing to multiple factors and the epidemiologic differences by global regions, these issues will need to be evaluated in each country taking into account various factors, including accuracy of risk assessment and cost-effectiveness of screening in never smokers. This report aims to outline current knowledge on risk factors for lung cancer in never smokers to propose research strategies for this topic and initiate a broader discussion on lung cancer screening of never smokers. Similar considerations can be made in current and ex-smokers, which do not fulfill the current screening inclusion criteria, but otherwise are at increased risk. Although screening of never smokers may in the future be effectively conducted, current evidence to support widespread implementation of this practice is lacking.
Copyright © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early detection; Epidemiology; Low-dose computed tomography; Lung cancer; Never-smokers; Screening

Mesh:

Substances:

Year:  2021        PMID: 34455065     DOI: 10.1016/j.jtho.2021.07.031

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors.

Authors:  Hyunwoo Lee; Jin Hee Park; Joungho Han; Young Mog Shim; Jhingook Kim; Yong Soo Choi; Hong Kwan Kim; Jong Ho Cho; Yoon-La Choi; Wan-Seop Kim
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

2.  Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Authors:  Jelena Spasic; Milena Cavic; Nemanja Stanic; Bojan Zaric; Tomi Kovacevic; Davorin Radosavljevic; Ljudmila Nagorni-Obradovic
Journal:  Dose Response       Date:  2022-06-28       Impact factor: 2.623

3.  Lung Cancer Screening With Low-dose Chest Computed Tomography: Experience From Radon-contaminated Regions in Kazakhstan.

Authors:  Alexandra Panina; Dilyara Kaidarova; Zhamilya Zholdybay; Akmaral Ainakulova; Jandos Amankulov; Dias Toleshbayev; Zhanar Zhakenova; Arman Khozhayev
Journal:  J Prev Med Public Health       Date:  2022-04-14

4.  Potential Overdiagnosis with CT Lung Cancer Screening in Taiwanese Female: Status in South Korea.

Authors:  Jin Mo Goo; Kyu-Won Jung; Hyae Young Kim; Yeol Kim
Journal:  Korean J Radiol       Date:  2022-06       Impact factor: 7.109

5.  Lung cancer: progress with prognosis and the changing state of play.

Authors:  Fraser J Brims; Annette McWilliams; Susan V Harden; Ken O'Byrne
Journal:  Med J Aust       Date:  2022-03-29       Impact factor: 12.776

6.  Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.

Authors:  Vera Jokic; Katarina Savic-Vujovic; Jelena Spasic; Zoran Bukumiric; Mladen Marinkovic; Davorin Radosavljevic; Milena Cavic
Journal:  Dose Response       Date:  2022-08-04       Impact factor: 2.623

7.  Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program.

Authors:  Zheng Wu; Fengwei Tan; Zhuoyu Yang; Fei Wang; Wei Cao; Chao Qin; Xuesi Dong; Yadi Zheng; Zilin Luo; Liang Zhao; Yiwen Yu; Yongjie Xu; Jiansong Ren; Jufang Shi; Hongda Chen; Jiang Li; Wei Tang; Sipeng Shen; Ning Wu; Wanqing Chen; Ni Li; Jie He
Journal:  Chin Med J (Engl)       Date:  2022-06-05       Impact factor: 6.133

8.  Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.

Authors:  Didier Debieuvre; Olivier Molinier; Lionel Falchero; Chrystèle Locher; Dorine Templement-Grangerat; Nicolas Meyer; Hugues Morel; Yannick Duval; Bernard Asselain; Alexia Letierce; Jean Trédaniel; Jean-Bernard Auliac; Olivier Bylicki; Lionel Moreau; Mathieu Fore; Romain Corre; Sébastien Couraud; Alexis Cortot
Journal:  Lancet Reg Health Eur       Date:  2022-08-29

Review 9.  Lung Cancer Screening in Asbestos-Exposed Populations.

Authors:  Steven B Markowitz
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.